Company Search:
Advanced Search
Sponsored Links
Diffusion Pharmaceuticals Inc Company Snapshot
Diffusion Pharmaceuticals Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Diffusion Pharmaceuticals Inc with three other companies in this sector in the United States: Kala Pharmaceuticals Inc (2013 sales of $50,000.00 ), Tocagen Inc ($90,000.00 ), and Tenax Therapeutics Inc ($92,683.00 of which 100% was Biotechnology Product).

Sales Analysis.
  Stock Performance Chart for Diffusion Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 1.42
(Figures in U.S. Dollars)
1 Week 13.6%   13 Weeks 6.0%  
4 Weeks -13.9%   52 Weeks -76.6%  
Diffusion Pharmaceuticals Inc Key Data:
  Ticker: DFFN Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2013 Sales 71,667
(Year Ending Jan 2014).
Employees: 10
  Currency: U.S. Dollars Market Cap: 20,620,857
  Fiscal Yr Ends: December Shares Outstanding: 14,521,730
  Share Type: Common Closely Held Shares: 3,074,898
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.